Submit to Special Issue Submit Abstract to Special Issue Review for Diagnostics Edit a Special Issue

Journal Menu

Journal Browser

Special Issue "Detection and Assessment of SARS-CoV-2 Variants"

Print Special Issue Flyer
Special Issue Editors
Special Issue Information
Keywords
Published Papers

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Diagnostic Microbiology and Infectious Disease".

Deadline for manuscript submissions: 31 August 2023 | Viewed by 3781

Share This Special Issue

Special Issue Editor

Prof. Dr. Hung-Sheng Shang

E-Mail Website
Guest Editor

Division of Clinical Pathology, Department of Pathology, Tri‑Service General Hospital, National Defense Medical Center, Taipei, Taiwan
Interests: clinical pathology; molecular diagnosis; genome; epidemiology

Special Issue Information

Dear Colleagues,

Since the first severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant Alpha was identified in England in late November 2021, mutations in the viral genome can increase transmissibility, facilitate escape from the human immune system, and/or alter biologically important phenotypes. The SARS-CoV-2 variants are classified as variants being monitored (VBMs), variants of interest (VOIs), variants of concern (VOCs), and variants of high consequence (VOHCs). There are two currently circulating SARS-CoV-2 VOCs (Delta and Omicron), and three previously circulating VOCs (Alpha, Beta, and Gamma) in a way that confers a fitness advantage to the virus, such as mutations in the spike (S) gene that affect antigenicity. Each characterized variant has mutations in the gene encoding the S protein (Omicron: 30 mutations; Delta: 10 mutations; Alpha: 7 mutations and 2 deletions; Beta: 9 mutations and 1 deletion; and Gamma: >10 mutations), compared to the sequence of the wild type index virus (Wuhan-Hu-1).

Previous studies have pointed out that viral genomic mutations leading to new variants of SARS-CoV-2 are a real challenge in tackling the global coronavirus disease (COVID-19). Understanding SARS-CoV-2 variants remains an issue of concern for all local government authorities and are critical for establishing and implementing effective public health measures.

This Special Issue on “Detection and Assessment of SARS-CoV-2 Variants” will cover all related areas, such as diagnostic applications, VOC pathogen detection, biomarker monitoring, and others of concern.

Prof. Dr. Hung-Sheng Shang
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

variant of concerns
Omicron
pathogen detection
biomarker

Published Papers (4 papers)

Download All Papers

Order results

Result details

Show export options Show export options

Select all

Export citation of selected articles as:

Research

Open AccessArticle

Detection of SARS-CoV-2 Variants via Different Diagnostics Assays Based on Single-Nucleotide Polymorphism Analysis

Eliana Specchiarello

Giulia Matusali

Fabrizio Carletti

Cesare Ernesto Maria Gruber

and

Diagnostics 2023, 13(9), 1573; https://doi.org/10.3390/diagnostics13091573 - 27 Apr 2023

Cited by 1 | Viewed by 583

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is characterized by fast evolution with the appearance of several variants. Next-Generation Sequencing (NGS) technology is considered the gold standard for monitoring known and new SARS-CoV-2 variants. However, the complexity of this technology renders this approach impracticable in laboratories located in areas with limited resources. We analyzed the capability of the ThermoFisher TaqPath COVID-19 RT-PCR (TaqPath) and the Seegene Novaplex SARS-CoV-2 Variant assay (Novaplex) to detect Omicron variants; the Allplex VariantII (Allplex) was also evaluated for Delta variants. Sanger sequencing (SaS) was the reference method. The results obtained with n = 355 nasopharyngeal samples were: negative with TaqPath, although positive with other qualitative molecular assays (n = 35); undetermined (n = 40) with both the assays; negative for the ∆69/70 mutation and confirmed as the Delta variant via SaS (n = 100); positive for ∆69/70 and confirmed as Omicron BA.1 via SaS (n = 80); negative for ∆69/70 and typed as Omicron BA.2 via SaS (n = 80). Novaplex typed 27.5% of samples as undetermined with TaqPath, 11.4% of samples as negative with TaqPath, and confirmed 100% of samples were Omicron subtypes. In total, 99/100 samples were confirmed as the Delta variant with Allplex with a positive per cent agreement (PPA) of 98% compared to SaS. As undermined samples with Novaplex showed RdRp median Ct values (Ct = 35.4) statistically higher than those of typed samples (median Ct value = 22.0; p < 0.0001, Mann–Whitney test), the inability to establish SARS-CoV-2 variants was probably linked to the low viral load. No amplification was obtained with SaS among all 35 negative TaqPath samples. Overall, 20% of samples which were typed as negative or undetermined with TaqPath, and among them, twelve were not typed even by SaS, but they were instead correctly identified with Novaplex. Although full-genome sequencing remains the elected method to characterize new strains, our data show the high ability of a SNP-based assay to identify VOCs, also resolving samples typed as undetermined with TaqPath. Full article

(This article belongs to the Special Issue Detection and Assessment of SARS-CoV-2 Variants)

► Show Figures

Figure 1

Open AccessFeature PaperArticle

Virus-Specific Stem Cell Memory CD8+ T Cells May Indicate a Long-Term Protection against Evolving SARS-CoV-2

and

Diagnostics 2023, 13(7), 1280; https://doi.org/10.3390/diagnostics13071280 - 28 Mar 2023

Viewed by 544

Abstract

Immune memory to SARS-CoV-2 is key for establishing herd immunity and limiting the spread of the virus. The duration and qualities of T-cell-mediated protection in the settings of constantly evolving pathogens remain an open question. We conducted a cross-sectional study of SARS-CoV-2-specific CD4+ and CD8+ T-cell responses at several time points over 18 months (30–750 days) post mild/moderate infection with the aim to identify suitable methods and biomarkers for evaluation of long-term T-cell memory in peripheral blood. Included were 107 samples from 95 donors infected during the periods 03/2020–07/2021 and 09/2021–03/2022, coinciding with the prevalence of B.1.1.7 (alpha) and B.1.617.2 (delta) variants in Bulgaria. SARS-CoV-2-specific IFNγ+ T cells were measured in ELISpot in parallel with flow cytometry detection of AIM+ total and stem cell-like memory (T_SCM) CD4+ and CD8+ T cells after in vitro stimulation with peptide pools corresponding to the original and delta variants. We show that, unlike IFNγ+ T cells, AIM+ virus-specific CD4+ and CD8+ T_SCM are more adequate markers of T cell memory, even beyond 18 months post-infection. In the settings of circulating and evolving viruses, CD8+ T_SCM is remarkably stable, back-differentiated into effectors, and delivers immediate protection, regardless of the initial priming strain. Full article

(This article belongs to the Special Issue Detection and Assessment of SARS-CoV-2 Variants)

► Show Figures

Figure 1

Open AccessArticle

Association between Vitamin D Status and Secondary Infections in Patients with Severe COVID-19 Admitted in the Intensive Care Unit of a Tertiary-Level Hospital in Turkey

Lutfiye Karcioglu Batur

and

Suna Koç

Diagnostics 2023, 13(1), 59; https://doi.org/10.3390/diagnostics13010059 - 26 Dec 2022

Viewed by 1009

Abstract

There are several studies showing that the vitamin D status can determine risk of COVID-19 infections, severity and mortality from coronavirus disease 2019 (COVID-19). However, the association between vitamin D (25(OH)D) and secondary infections in the prognosis of COVID-19 patients has not been reported yet. The aim was to investigate whether the vitamin D status affects the rates of secondary infections in patients with severe COVID-19 hospitalized in the intensive care unit (ICU) of a tertiary-level hospital in Turkey. The data of 194 patients with diagnosis of severe COVID-19 who were admitted to the ICU from March 2020 to June 2021 and older than 18 years were evaluated in this retrospective study. The patients were divided into two groups according to total serum 25(OH)D level as normal group (≥20 ng/mL) and low group (<20 ng/mL). The 25(OH)D level was low in 118 (60.8%) and normal in 76 (39.2%) patients. The mean age of the low group was significantly higher than that of the normal group (67.02 ± 14.47 vs. 61.70 ± 14.38; p = 0.013). The systolic and diastolic blood pressure as well as the Glasgow coma scale score of the low group were significantly lower than that of the normal group (p = 0.004, 0.002 and 0.001, respectively). The intubation rate and APACHE (Acute Physiology and Chronic Health Evaluation) score of the low group was significantly higher than that of the normal group (p = 0.001). The platelets number and blood pH decreased, and the neutrophil/lymphocyte ratio, procalcitonin, lactate, urea, creatinine and lactate dehydrogenase concentrations increased significantly in the low group (p < 0.05). The mortality rate was 79.7% in the low group and 22.4% in the normal group (p < 0.001). Microbiological growth was observed in 68.6% of the normal group and 52.6% of the normal group (p = 0.025). The number of cultures with resistant bacteria was significantly higher in the low group (25.9%) than that in the normal group (17.5%) (p = 0.035). The severe COVID-19 patients hospitalized with vitamin D deficiency may have increased risks of poor prognosis and mortality due to secondary infections in the ICU. Full article

(This article belongs to the Special Issue Detection and Assessment of SARS-CoV-2 Variants)

Open AccessCommunication

SARS-CoV-2 RT-PCR to Screen for B.1.617.2 (Delta) Variant of Concern

and

Diagnostics 2022, 12(9), 2056; https://doi.org/10.3390/diagnostics12092056 - 24 Aug 2022

Cited by 1 | Viewed by 1067

Abstract

The continuous transmission and evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has required that diagnostic capabilities be constantly monitored and updated as new variants emerge and prior variants disappear. Although whole genome sequencing provides full characterisation of SARS-CoV-2 directly from patient samples, this has limited throughput and requires sufficient resources. To enhance screening for circulating variants, we designed a rapid in-house RT-PCR assay to target a spike mutation (D950N) in Delta variants, which is not detected in the remaining variants of concern (VOCs). Assay sensitivity for detecting Delta variants was 93% and specificity was 100% using a sequenced sample bank of several lineages. As the D950N mutation is prevalent in >95% of the global Delta variant sequences deposited in GISAID, this assay has the potential to provide rapid results to determine if the samples are presumptively Delta variants and can support clinicians in timely clinical decision-making for effective treatments and surveillance. Full article

(This article belongs to the Special Issue Detection and Assessment of SARS-CoV-2 Variants)

Show export options Show export options

Select all

Export citation of selected articles as:

Displaying articles 1-4

Journal Menu

Journal Browser

Special Issue "Detection and Assessment of SARS-CoV-2 Variants"

Share This Special Issue

Special Issue Editor

Special Issue Information

Keywords

Published Papers (4 papers)

Research

Further Information

Guidelines

MDPI Initiatives

Follow MDPI